Personalis Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Personalis stock.
View analyst ratings for Personalis or view top-rated stocks.

Wall Street analysts have given Personalis a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Personalis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Personalis saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 3,060,000 shares, an increase of 34.2% from the February 28th total of 2,280,000 shares. Based on an average trading volume of 1,100,000 shares, the days-to-cover ratio is presently 2.8 days.
View Personalis' Short Interest.

Personalis is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Personalis.

Personalis, Inc. (NASDAQ:PSNL) released its earnings results on Thursday, February, 25th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by $0.04. Personalis had a negative net margin of 45.13% and a negative trailing twelve-month return on equity of 27.53%.
View Personalis' earnings history.

Personalis' stock was trading at $6.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PSNL shares have increased by 268.6% and is now trading at $22.19.
View which stocks have been most impacted by COVID-19.

Personalis issued an update on its first quarter 2021 After-Hours earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $20.3-20.3 million, compared to the consensus revenue estimate of $20.13 million.

9 Wall Street analysts have issued 12-month target prices for Personalis' shares. Their forecasts range from $24.00 to $50.00. On average, they expect Personalis' stock price to reach $40.56 in the next twelve months. This suggests a possible upside of 82.8% from the stock's current price.
View analysts' price targets for Personalis or view top-rated stocks among Wall Street analysts.

17 employees have rated Personalis CEO John West on Glassdoor.com. John West has an approval rating of 75% among Personalis' employees.

Some companies that are related to Personalis include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Fulgent Genetics (FLGT), Genetron (GTH), Castle Biosciences (CSTL), DermTech (DMTK), RadNet (RDNT), Renalytix AI (RNLX), Celcuity (CELC), Centogene (CNTG), Exagen (XGN), Progenity (PROG), Enzo Biochem (ENZ) and OpGen (OPGN).
View all of PSNL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and (APHA).

(PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PSNL stock can currently be purchased for approximately $22.19.

Personalis has a market capitalization of $971.26 million and generates $65.21 million in revenue each year. The company earns $-25,080,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis.

Personalis employs 234 workers across the globe.

The official website for Personalis is www.personalis.com.

Personalis is headquartered at 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]